Crisugabalin provides significant improvement in average daily pain score and shows promise as a postherpetic neuralgia treatment.

Over the past month, shares of this health care real estate investment trust have returned +3.4%, compared to the Zacks S&P 500 ... between trends in earnings estimate revisions and short-term stock ...

The Bank does not provide concrete forecasts of where interest rates will end up, but we're never short of analysts putting their view forward. Respected economists at Capital Economics now anticipate ...

There are 52 results, Your applied filters are, length short, ...